Stryker reported that its sales were down more than $230 million due to its faulty hip replacements, the Stryker Rejuvenate and Stryker ABG II Modular hip replacement system. The 77% decrease in profits are directly related to the Rejuvenate recall and ABG II recall the company issued in July 2012 after studies showed the devices were failing at an alarming rate.
Stryker will likely incur additional legal costs for its faulty hip implants, as patients have begun filing Rejuvenate lawsuits alleging that the metal-on-metal hip devices caused serious injuries. Stryker hip replacement side effects include an increased risk of fretting or corrosion, which can lead to tissue damage, limited mobility and metallosis.
The British Medical Journal found that debris from metal hip replacements can leak into the bloodstream, causing blood poisoning from toxic levels of cobalt and chromium. Stryker is one of several companies facing hip replacement lawsuits related to its defective implants. Manufacturer Johnson & Johnson recently agreed to settle hip replacement lawsuits related to its device for more than $4 billion.